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Abstract
Background: Bacterial infections have been linked to malignancies due to their ability to induce chronic
inflammation. We investigated the association of oral bacteria in oral squamous cell carcinoma (OSCC/tumor)
tissues and compared with adjacent non-tumor mucosa sampled 5 cm distant from the same patient (n = 10).
By using culture-independent 16S rRNA approaches, denaturing gradient gel electrophoresis (DGGE) and cloning
and sequencing, we assessed the total bacterial diversity in these clinical samples.
Results: DGGE fingerprints showed variations in the band intensity profiles within non-tumor and tumor tissues of
the same patient and among the two groups. The clonal analysis indicated that from a total of 1200 sequences
characterized, 80 bacterial species/phylotypes were detected representing six phyla, Firmicutes, Bacteroidetes,
Proteobacteria, Fusobacteria, Actinobacteria and uncultivated TM7 in non-tumor and tumor libraries. In combined
library, 12 classes, 16 order, 26 families and 40 genera were observed. Bacterial species, Streptococcus sp. oral taxon
058, Peptostreptococcus stomatis, Streptococcus salivarius, Streptococcus gordonii, Gemella haemolysans, Gemella
morbillorum, Johnsonella ignava and Streptococcus parasanguinis I were highly associated with tumor site where
as Granulicatella adiacens was prevalent at non-tumor site. Streptococcus intermedius was present in 70% of both
non-tumor and tumor sites.
Conclusions: The underlying changes in the bacterial diversity in the oral mucosal tissues from non-tumor and
tumor sites of OSCC subjects indicated a shift in bacterial colonization. These most prevalent or unique bacterial
species/phylotypes present in tumor tissues may be associated with OSCC and needs to be further investigated
with a larger sample size.
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Background
Oral cancer is one of the ten most prevalent cancers in
the world with more than 90% of mouth neoplasms
being squamous cell carcinoma that has its origin from
the oral mucosa [1-3]. During the year 2011, in United
States, approximately, 39,400 new cases and 7,900 deaths
were estimated attributing to cancer of oral cavity and
pharynx [4]. Five year survival rates for persons with this
medical condition are currently only 60.9% [4]. The early
detection of oral cancer at initial stages is critical and
requires less radical treatment for patient’s survival and
improving quality of life. The pathogenesis of OSCC is
attributed mainly to smoking, heavy alcohol consump-
tion and smokeless tobacco products [5-7]. Other pos-
sible risk factors include viral infections [8,9], infection
with Candida species [10], periodontitis [11,12], poor
oral hygiene [13], poor dental status [14] and chronic
bacterial infections and inflammation [5,6,15-17].
The association of bacterial infection and cancer is
classically represented by Helicobacter pylori and its
involvement in gastric adenocarcinoma and mucosa asso-
ciated lymphoid tissue (MALT) lymphoma [18]. Some
studies suggests possible link between Salmonella typhi
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and gall bladder cancer, Streptococcus bovis and colon can-
cer, Chlamydophila pneumoniae and lung cancer, Bartonella
species and vascular tumor formation, Propionibacterium
acnes and prostate cancer and Escherichia coli in inflamma-
tory bowel disease with increased risk of colon cancer
[15,19,20]. These findings were confirmed by using several
animal (mice) models for Helicobacter hepaticus associated
with hepatocellular carcinoma [21], colon cancer [22]
and cancer in mammary glands [23]. There is growing
evidence that bacterial infection is causally related to
carcinogenesis.
Several mechanisms for possible bacterial association
in carcinogenesis may include chronic infection by eva-
sion of immune system and immune suppression [24],
or induction of chronic inflammation [25], or direct or
indirect interference with eukaryotic cell cycle and sig-
naling pathways [8,15], or via metabolism of potential
carcinogenic substances [7]. The host cells are susceptible
to microbial endotoxins (lipopolysaccharides), enzymes
(proteases, collagenases, fibrinolysin and phospholipase)
and their metabolic by-products (hydrogen sulfide,
ammonia and fatty acids) and may directly induce muta-
tions in tumor suppressor genes and proto-oncogenes or
alter signaling pathways that affect cell proliferation and/
or survival of epithelial cells [8,15,24]. Microorganisms
and their products activate neutrophils, macrophages,
monocytes, lymphocytes, fibroblasts and epithelial cells to
generate reactive species (hydrogen peroxide and oxygen
radicals), reactive nitrogen species (nitric oxides), reactive
lipids and metabolites (malondialdehyde and 4-hydroxy-2
-nonenal) and matrix metalloproteases. These compounds
can induce DNA damage in epithelial cells [20] and dir-
ectly affect tumor growth by activating tumor cell toll-like
receptors (TLR) that eventually leads to nuclear translo-
cation of the transcription factor NF-kB and cytokines
production [26,27]. These cytokines are produced in dys-
regulated fashion and have roles in cell growth, invasion
and interruption of tumor suppression, immune status
and even survival [28]. It is unclear whether these media-
tors are critical for the development and/or growth of
tumors and/or whether they constitute a permissive envir-
onment for the progression of malignancies [29]. Elevated
levels of certain proinflammatory, proangiogenic NF-kB
dependent cytokines TNF-α, IL-1, IL-6, IL-8, GM-CSF
and VEGF were observed in serum, saliva, and tissue
specimens of patients with oral cancer [30,31].
The oral cavity harbors diversified microflora with
more than 750 distinct bacterial taxa [14] that colonize
host tissues and co-aggregate with one another [32]. Any
loss in integrity of oral epithelial barrier exposes the
underlying tissues to various aerobic and anaerobic
microflora of oral cavity [33]. Hence, the local and sys-
temic polymicrobial mucosal infections may be a result
of invading potentially pathogenic microorganism of
extra-oral origin or a shift within the normal commensal
microflora taken up by opportunistic microflora in
immuno-compromised individuals [33].
Previous studies on oral microbiota of patients with
and without OSCC using culture-dependent [10,33-36]
and culture-independent [37-40] techniques indicated
bacterial community profiles to be highly correlated at
phylum level but diverse at genus level. Hooper et al.
[34,38] observed that most of the taxa in non-tumor and
tumor tissues were known members of oral cavity and
majority of those in tumor tissue were saccharolytic and
aciduric species. Our studies on bacterial diversity in
saliva samples by 454 pyrosequencing revealed 244 bac-
terial OTUs exclusive to OSCC patients (n = 3) as com-
pared to non-OSCC controls (n= 2) [40]. To establish
the role of bacteria in OSCC, it is important to deter-
mine the differences in the colonization of oral bacteria
in non-tumor and tumor tissues. We hypothesized that
any differences in bacterial profile at tumor sites in con-
trast to non-tumor sites may indicate its involvement in
tumor pathogenesis.
We used 16S rRNA based two culture-independent
methods, denaturing gradient gel electrophoresis and
sequencing to elucidate the total oral microbiota in non-
tumor and tumor tissues of OSCC patients. This may
facilitate to identify the microbial transition in non-
tumor and tumor tissues and understand better the
association of bacterial colonization in OSCC.
Methods
Subject selection and sampling procedure
Twenty oral tissue samples, 10 each from non-tumor
and tumor sites of 10 patients with squamous cell car-
cinoma of oral tongue and floor of the mouth, median
age 59 years (53% male and 47% female) were obtained
from Memorial Sloan-Kettering Cancer Center (MSKCC)
Tissue Bank, refer Estilo et al. and Singh et al. [41-43]
for clinical details. The subjects had a history of smoking
and drinking and were not on antibiotics for a month
before sampling. The study was approved by institutional
review boards at MSKCC and NYU School of Medicine
and written informed consent was obtained from all
participants involved in this study. The tissues were
collected following guidelines established by Institutional
Review Board at MSKCC and tumors were identified
according to tumor-node-metastasis classification by
American Joint Committee on Cancer/Union Inter-
national Cancer Center.
For this study, to have a homogenous sample popula-
tion and to control the effect of confounding factors on
bacterial colonization, we used non-tumor tissue from
upper aerodigestive tract as a control, resected 5 cm dis-
tant from the tumor area or contralateral side of the
same OSCC patient and confirmed histologically as
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normal mucosae [42]. The tissue samples were processed
to include all bacteria (on the surface and within the tis-
sue) to detect the total bacterial diversity in oral mucosa.
The samples were procured and stored at −80°C till
further analysis.
DNA extraction from tissue samples
Tissue specimens were pretreated as mentioned earlier
by Ji et al. [44]. Briefly, the tissues were suspended in
500 μL of sterile phosphate-buffered saline (PBS), vor-
texed for 30 seconds and sonicated for 5 and 10 seconds
respectively. Proteinase K (2.5 μg/mL) was added for
digestion and incubated overnight at 55°C, if required,
homogenized with sterile disposable pestle and vor-
texed. The bacterial genomic DNA was extracted by
modified Epicentre protocol (Epicentre Biotechnologies,
Madison, WI) and purified with phenol-chloroform
extraction [45]. Samples were analyzed qualitatively
and quantitatively by NanoDrop ND 1000 spectropho-
tometer (NanoDrop Technologies Inc., Wilmington, DE).
All samples were stored at −20°C till further analysis. For
PCR assays, the DNA concentration was adjusted to
20 ng/μL.
16S rDNA amplification
The 16S rDNA samples were amplified as described
earlier [44] using universal primer pair 8F and 1492R
[46-48] for cloning. PCR reactions were run at 95°C for
5 min, followed by 30 cycles of denaturation at 95°C for
1 min, annealing at 52°C for 1 min, and elongation at
72°C for 1 min with final elongation at 72°C for 5 min.
The nested PCR was performed targeting V4-V5 hyper-
variable region with another set of eubacterial primers,
prbac1 and prbac2 [49] with 40-nucleotide GC clamp
[50] added to 5’ end of prbac1 for DGGE assay. The con-
ditions of nested PCR were 3 min preheating at 94°C, 35
cycles each at 94°C (30 seconds), 63°C (40 seconds), and
72°C (1 min), final extension at 72°C for 7 min. For both
PCR assays, the reaction system was 50 μL comprising
1 μL DNA template, 5 U Taq DNA polymerase (Invitrogen,
Carlsbad, CA), 5 μL 10x PCR buffer, 1.5 μL MgCl2
(50 mM), 4 μL dNTP mixture (2.5 mM each) and 50 pmol
of each primer.
DGGE assay
PCR products from nested PCR were analyzed for
sequence polymorphism on 40% to 60% linear DNA
denaturing gradient polyacrylamide gel, 8.0%w/v. 30 μL
of each were loaded on DGGE gel with standard species-
specific DGGE reference markers [40,51] resolved by
DCode system (Bio-Rad, Hercules, CA). The gels were
run for 16 hr at 58°C and 60 V in 1x Tris-acetate-EDTA
(TAE) buffer, pH 8.5 and stained with ethidium bromide
solution (0.5 μg/mL) for 15 min. The images were digitally
documented using Alpha Imager 3300 system (Alpha
Innotech Corporation, San Leandro, CA).
Cluster and statistical analyses of DGGE microbial profiles
DGGE gel pattern of amplicons were analyzed with the
aid of Fingerprinting II Informatix Software (Bio-Rad)
and interpreted statistically [52]. The gels were normal-
ized with DGGE standard markers and background sub-
tracted using mathematical algorithms based on spectral
analysis of overall densitometric curves. The similarity
among samples was calculated by Dice coefficient. Den-
drogram was configured from average matrix by Ward
analysis. The variations in microbial profiles of non-
tumor and tumor tissues were assessed by comparing
inter- and intra- groups DGGE profiles of PCR amplified
segments. Differences were examined for statistical sig-
nificance using Mann–Whitney U test and Chi-square
test. Statistical analysis was performed using SPSS soft-
ware v. 17.0 (SPSS inc., Chicago, IL).
Cloning and sequencing
PCR amplicons were ligated to pCR4-TOPO vector and
transformed into E. coli TOP10 cells using TOPO-TA
cloning kit according to manufacturer’s instructions
(Invitrogen). From each sample, about 95–96 clones
were picked and a total of 1914 clones were sequenced
unidirectional (Beckman Coulter Genomics, Beverly,
MA) using BigDye Terminator v3.1 and 806r sequencing
primer and analyzed on ABI PRISM 3730xl coupled with
Agencourt CleanSEQ dye terminator removal for gener-
ation of long high quality Sanger sequencing reads.
About 1200 sequences with Phred 20 and average read
length of 700 bases were trimmed by removing vector
sequences and adjusted for quality values. The majority
of single sequence read length was between 350–900
bases. All the trimmed sequences were verified manually
for vector sequences using EMBOSS pairwise alignment
algorithms [53].
Phylogenetic analysis of sequences in group specific
libraries
Sequences were aligned with Greengenes Nast aligner
(http://greengenes.lbl.gov) [54] and then checked for chi-
meras on greengenes chimera check program supported
by Bellerophon [54,55]. About 0.7% sequences were
chimeric and eliminated from analysis. The sequences
with 350 to 900 bases were analyzed against 16S rRNA
reference sequences of Human Oral Microbiome Data-
base (HOMD, version 10.1) [56,57]. Sequence identifica-
tion requires a single read of approximately 350 to 500
bases [58]. The threshold assigned for BLAST identifica-
tion of partial sequences was ≥98% similarity for species/
phylotypes. Majority of sequences could be identified to
species/phylotype level. The sequences with <98%
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identity were characterized only till genus level and
considered unclassified sequences at species level.
Non-tumor and tumor libraries were constructed from
clonal analysis. These sequences were also analyzed
using Ribosomal Database Project (RDP, Release 10) [59].
The relative distribution of abundance for phylogenetic
groups in two different libraries was compared by chi-
square test. The intra- (within) and inter- (between)
groups bacterial species/phylotypes in 16S clonal libraries
were evaluated. In analysis, for representation of bacterial
taxa, the term, species refers to named cultivated species
and unnamed cultivated taxon and phylotypes refers to
non-cultivable or yet- uncultured species.
Diversity and richness estimation of group specific
libraries
Richness estimator, Chao1 was determined by ESTI-
MATES v. 7 [60] and rarefaction curves, rank abundance
and diversity indices performed in PAST v. 1.89 [61].
The species rarefaction of the entire dataset was com-
puted by individual rarefaction method. The percentage
of coverage was calculated by Good’s method using
equation (1−n/N) x 100, where n is number of singletons
represented by one clone in the library and N is total
number of sequences in the sample library [62]. The
diversity of each sampled sequence set was estimated by
using Shannon (H’) and Simpson (1–D) indices within
PAST application. The Shannon index of evenness was
calculated with the formula E = e^H/S, where H is Shannon
diversity index and S is number of taxa (species/phylotypes)
in that group.
Results
In this study, DGGE was used as a method for preliminary
and rapid assessment of bacterial diversity in tumor and
non-tumor tissues. DGGE gel profiles of non-tumor and
tumor samples (n = 20) were analyzed after normalization
of gels with species-specific markers (Figure 1). In total,
68 and 64 bands were distinct to non-tumor and tumor
groups respectively of which 8 bands were exclusive to
non-tumor samples while 4 bands exclusive to tumor
group. Each band may correspond to one or more bac-
terial species. The band distribution of bacterial popula-
tion in individual samples ranged from 20 to 26 (mean
22.40 ± 1.71 SD) in non-tumor where as 15 to 26 bands
(mean 20.60 ± 3.10 SD) in tumor groups. The Mann–
Whitney U test to compare the Shannon-Weaver in-
dexes of diversity (H’) in non-tumor and tumor samples
showed no significant differences (p> 0.05, two-tailed)
in oral microbiota between two sample groups. The
inter- group similarities were found to be 40% to 80% by
cluster analysis (Figure 2). Most of the clinically distinct
samples (non-tumor and tumor) from the same patients
clustered together with exception of one sample (184_N
and 184_T) as seen in their intensity profiles.
Similarity index (SI) was calculated based on the total
number of high and low intensity bands per lane and
position of band migration reflecting number of bands
the two lanes have in common. The values signify simi-
larities in bacterial composition between non-tumor and
tumor groups (Table 1). The tumor samples (intra-
group), 1457_T and 527_T showed total dissimilarity in
their profiles despite sharing the same group. The band
similarity correlation was highest in non-tumor and
tumor tissue samples (inter- group), 142_N/142_T
(77.27%) and 146_N/146_T (71.43%) from the same
patient indicating that most of the microbiota were
common at both the sites but there were changes in the
bacterial composition. Chi-square test indicated significant
differences in intra- and inter- groups bacterial profiles
(X2 =10.76, p=0.005).
The alterations in DGGE fingerprinting profiles
indicated that different bacteria colonize the two oral
sites, non-tumor and tumor of OSCC patients. This
prompted us to conduct cloning and sequencing
studies using 16S rDNA amplification to identify
microbiotal populations at these sites. The clonal
libraries with clinical distinctions were constructed
with approximately 1200 high quality sequences from
the rDNA inserts of non-tumor and tumor tissues.
About 276 (~22.9%) sequences with <350 bases and
14 chimeric sequences (1.2%) were eliminated from
analysis. The filtered 914 (75.9%) sequences of 350–900
bases from combined (non-tumor and tumor) library were
characterized, of which 107 sequences (8.9%) with <98%
sequence identity accounted for genus level classification
and were uncharacterized at species level. The remaining
807 (67%) sequences having >98% sequence identity to 16S
rRNA reference sequences in HOMD were classified to
species level.
Figure 3a shows the % distribution of phyla at tumor and
non-tumor sites of the patient population. The filtered 914
sequences matched 6 bacterial phyla, in their degree of
dominance, Firmicutes, Bacteroidetes, Proteobacteria,
Fusobacteria, Actinobacteria and uncultivated TM7 were
detected in both non-tumor and tumor libraries
(Figure 3b). The frequency of phylum Firmicutes was
major in tumor tissues (85%) as compared to non-tumor
tissues (74.6%) whereas the frequency of other phyla was
higher in non-tumor library. The composition of bacterial
communities at tumor site was different in comparison to
the non-tumor site in most of the patients (Figure 4a). In
combined library, 12 classes, 16 order, 26 families and 40
genera were observed and their relative distribution in
individual non-tumor and tumor library is demonstrated
in (see Additional file 1: Figure S1, Additional file 2:
Figure S2, Additional file 3: Figure S3) and Figure 4b
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respectively. The most prevalent classes were Bacilli
(66.6%) that includes order, Lactobacillales (54.8%) and
Bacillales (11.8%) in tumor library while Clostridia
(20.5%) and Bacteroides (11.8%) in non-tumor library.
The distribution of relative abundance of 40 represen-
tative genera in combined library (Figure 4b) was
predominated by Streptococcus (50.8%), Gemella (11.6%),
Parvimonas (4.6%), Peptostreptococcus (2.8%), Xanthomonas
(2.4%), Johnsonella (1.6%), Solobacterium (1.6%), Atopobium
(1.2%) and Eubacterium[11][G-1] (0.8%), in tumor library
while Prevotella (11.6%), Veillonella (9.9%), Granulicatella
(3.9%), Escherichia coli (2.4%), Oribacterium (2.2%),
Fusobacterium (1.9%), Actinomyces (1.4%), Megasphaera
(1.4%), Afipia (1.2%) and Leptotrichia (1.0%) in non-tumor
library. Among others, genera Capnocytophaga, Selenomonas
and Leptothrix were exclusive to non-tumor (control) tissues
and Eubacterium[11][G-3], Campylobacter and Catonella,
confined only to tumor tissues. Figure 4c shows the relative
shift from gram-negative to gram-positive microbiota by
an increase of 19% in tumor tissue samples than in
control non-tumor samples. Also, it was observed that
the two groups shared 25 genera, while 7 genera were
exclusive to non-tumor group and 8 genera to tumor
group (Figure 4c).
The core of pie chart shows % distribution of 914 total
sequences in terms of % homology to curated 16S rRNA
sequences in HOMD (Figure 5). The outer concentric of
pie chart depicts total oral bacterial taxa with >98%
identity contributing to named cultivable species (78.6%),
unnamed cultivable species (5.9%) and non-cultivable or
uncultured phylotypes (3.8%) and the sequences with
<98% identity are unclassified species (11.7%) characterized
only to genus level. These total sequences in RDP showed
homology with ~60% of uncultured phylotypes. Therefore,
the sequences analyzed with HOMD were taken into
consideration for species level identification. The venn
diagrams (Figure 5) are embedded to corresponding section
of pie chart except for the unclassified sequences and the
inset values in two subsets (non-tumor and tumor) cor-
relates to observed bacterial species unique to that particu-
lar library. The number of species shared or common to
both the groups is seen in overlapping section of subsets.
In total, 80 bacterial species/phylotypes were detected,
57 in non-tumor and 59 in tumor library. The unnamed
Figure 1 DGGE profile of microbial communities from two clinically distinct non-tumor and tumor groups. N–Non-tumor; T–Tumor;
Marker I & II: DGGE reference markers correspond to 16S rRNA gene fragments from quoted specific bacterial species [Marker I: 1. Fusobacterium
nucleatum subsp. vincenti (ATCC 49256); 2. Fusobacterium nucleatum subsp. nucleatum (ATCC 25586); 3. Streptococcus sanguinis (ATCC 10556);
4. Streptococcus oralis (ATCC 35037); 5. Streptococcus salivarius (ATCC 7073); 6. Streptococcus mutans (UA 159); 7. Lactobacillus paracasei (ATCC
25598); 8. Porphyromonas gingivalis (ATCC 33277); 9. Actinomyces odontolyticus (ATCC 17929);10. Actinomyces naeslundii (ATCC 12104), Marker II:
1. F. nucleatum subsp. vincenti (ATCC 49256); 2. F. nucleatum subsp. nucleatum (ATCC 25586); 3. Bacteroides forsythus (ATCC 43037); 4. S. sanguinis
(ATCC 10556); 5. S. oralis (ATCC 35037); 6. Veillonella parvula (ATCC 17745); 7. Prevotella intermedia (ATCC 25611); 8. Aggregatibacter
actinomycemcomitans (ATCC 43717); 9. P. gingivalis (ATCC 33277); 10. A.odontolyticus (ATCC 17929); 11. A. naeslundii (ATCC 12104)].
Pushalkar et al. BMC Microbiology 2012, 12:144 Page 5 of 15
http://www.biomedcentral.com/1471-2180/12/144
cultivable biota, Actinomyces sp. oral taxon 181, phylo-
type Leptotrichia sp. oral taxon 215, and certain named
bacterial species, Prevotella histicola, Prevotella melani-
nogenica, Prevotella pallens, Fusobacterium nucleatum
ss. nucleatum, Escherichia coli and Neisseria flavescens
were detected at non-tumor site while Atopobium
parvulum and Fusobacterium nucleatum ss. vincentii at
tumor site (Figure 6a). The microbiota associated
with phylum Firmicutes showed interesting switch in
profile (Figure 6b). Species, Granulicatella adiacens,
Mogibacterium diversum, Parvimonas micra, Streptococcus
anginosus, Streptococcus cristatus, Streptococcus mitis
and Veillonella dispar were prevalent at non-tumor site
of the OSCC patients. The unnamed cultivable taxon,
Streptococcus sp. oral taxon 058, and named cultivable
bacterial species, Gemella haemolysans, Gemella
morbillorum, Gemella sanguinis, Johnsonella ignava,
Peptostreptococcus stomatis, Streptococcus gordonii,
Streptococcus parasanguinis I, Streptococcus salivarius
were highly associated to tumor site. Streptococcus sp.
oral taxon 071 and Selenomonas sputigena were
confined to non-tumor site whereas Parvimonas sp.
oral taxon 110, Eubacterium [11][G-1] infirmum and
Eubacterium [XI][G-3] brachy were exclusive to tumor
site. Streptococcus intermedius was the most prevalent
species. Streptococcus parasanguinis II and Oribacterium
sinus were detected at both sites. Some observed bacterial
species/phyloypes were less frequent in OSCC patients.
The species richness, coverage, diversity and evenness
were estimated for two independent and combined set
of libraries (Table 2). Shannon-Weaver and Simpson di-
versity indices revealed higher values indicating a huge
species diversity in two libraries but no significant differ-
ences, Shannon diversity t test, p= 0.07 (p> 0.05). How-
ever, the richness estimators, Chao1 and ACE were
higher in tumor library than in non-tumor library. Even-
ness was greater with non-tumor samples as compared
to tumor samples suggesting less abundant species
at tumor site. Good’s coverage of the combined library
was ~98% suggesting that 2 additional phylotypes would
be recognized if 100 more clones were screened.
Individual-based rarefaction curves calculated using
PAST for the two library sets showed asymptote curve
(see Additional file 4: Figure S4a) at actual community
richness depicting that libraries were large enough to rep-
resent majority of oral bacterial species in the sampled
subsets. Rank abundance curves were plotted to compare
how well the communities have been sampled (see Add-
itional file 4: Figure S4b). A long right-hand tail indicated
rare species with few abundant species in both libraries.
Discussion
Bacteria have the capacity to penetrate and invade vari-
ous epithelial cells colonizing and inducing inflammation
which may plausibly associate to cancer progression
[63,64]. For example, H. pyroli have been known to be
Figure 2 Dendrogram representing the fingerprinting intensity profile of two clinically distinct samples from non-tumor and tumor
tissues. N–Non-tumor; T–Tumor.
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Table 1 Similarity index of DGGE fingerprinting pattern from two clinically distinct non-tumor and tumor groups
Similarity Index (%)
140_N 140_T 64_N 64_T 1293_N 1293_T 211_N 211_T 184_T 527_N 527_T 146_N 146_T 184_N 164_N 164_T 142_N 142_T 1457_N 1457_T
140_N 100
140_T 47.83 100
64_N 35.56 35.56 100
64_T 39.13 43.48 66.67 100
1293_N 41.87 27.91 42.86 41.87 100
1293_T 30 30 35.9 40 59.46 100
211_N 31.11 31.11 36.37 44.45 38.1 30.77 100
211_T 50 36.37 32.56 54.55 34.15 31.58 65.12 100
184_T 41.87 27.91 33.33 37.21 50 32.43 42.86 58.54 100
527_N 36.37 45.46 46.51 50 39.03 36.85 41.87 42.86 39.03 100
527_T 42.11 31.58 32.43 42.11 34.29 31.25 43.25 44.45 45.72 50 100
146_N 27.27 54.55 37.21 50 34.15 21.05 32.56 47.62 48.78 52.39 44.45 100
146_T 36.37 54.55 37.21 54.55 34.15 26.32 55.81 57.15 48.78 42.86 50 71.43 100
184_N 31.11 35.56 27.27 40 28.57 20.51 45.46 51.17 47.62 51.17 32.43 65.12 65.12 100
164_N 20.41 36.74 29.17 28.57 26.09 37.21 25 25.53 26.09 12.77 19.51 38.3 12.77 33.33 100
164_T 24.49 28.57 20.83 24.49 21.74 27.91 16.67 21.28 21.74 17.03 24.39 21.28 25.53 16.67 38.47 100
142_N 34.05 34.05 30.44 25.53 31.82 43.91 17.39 35.56 40.91 13.33 30.77 40 35.56 30.44 56.01 36.01 100
142_T 32.56 46.51 33.33 32.56 40 27.03 33.33 43.91 40 24.39 51.43 68.29 53.66 47.62 26.09 34.79 77.27 100
1457_N 43.48 21.74 22.23 21.74 41.87 30 22.23 36.37 41.87 18.19 31.58 31.82 22.73 31.11 36.74 40.82 46.81 41.87 100



















associated to inflammation of gastric mucosa leading to
gastritis, peptic ulcers, gastric carcinoma and gastric
mucosa-associated lymphoid tissue (MALT) lymphomas
[18]. Recently, a link between periodontal disease and
cancer has been suggested and the hypothetical propos-
ition is the chronic nature of inflammatory process
underlying periodontitis [64,65]. To the best of our
knowledge, this is the first report using DGGE in parallel
to sequencing for profiling bacterial flora and compares
the diversity in non-tumor and tumor tissues from same
individual. Here, we used homogenous population to
control various confounding factors and hence did not
compare bacterial colonization within healthy indivi-
duals but screened the normal mucosa collected from
the same subject. Thus the role of microbes in oral
diseases can be predicted looking at the changes in indi-
genous (non-tumor) and diseased (tumor) microenviron-
ments. DGGE allows rapid assessment of bacterial
diversity in various environments and we have extensively
used this technique in our earlier studies on saliva and
cariogenicity [45,51,52]. The fingerprints represents
separation of DNA fragments of same length based on
differences in nucleotide and each individual band relates
to one or more bacterial species [66].
In this study, the observed differences in DGGE pro-
files of inter- group, 22.73%–90.24% among non-tumor
and tumor groups, and intra- group diversity, 34.88%–
87.23% within non-tumor group and 41.46%–100%
within tumor group, signified some underlying changes
in bacterial colonization of the tissues. Thus, even slight
differences in bacterial profile of non-tumor and tumor
tissues seem significant as samples were procured from
the same individual. It is not surprising that fingerprints
showed no significant differences in mean total number
of bands. DGGE is a semi-quantitative method and the
band intensities are also influenced by 16S rRNA gene
copy numbers or co-migration of two or more sequence
types or combination of these [67,68]. However, the rela-
tive distribution of more intense bands may represent spe-
cies indigenous and abundant in oral microenvironment.
The less intense bands indicated indigenous but less rich
species or species in low numbers. Some species that were
a. 
b. 
Figure 3 Distribution of relative abundance of phyla in (a) Individual sample set, non-tumor and tumor sites of each OSCC patient
and; (b) Cumulative non-tumor and tumor libraries, as detected by HOMD and RDP. N–Non-tumor; T–Tumor .





Figure 4 Distribution of relative abundance of genera at (a) Non-tumor and tumor sites of each OSCC subject; and (b) Cumulative
non-tumor and tumor libraries, as detected by HOMD and RDP; (c) Pie-chart shows the relative prevalence of gram-negative and
gram-positive bacteria and venn diagram depicts the genera in tissue samples of OSCC subjects. *p< 0.1. N–Non-tumor; T–Tumor.
Pie-chart shows the relative shift of gram-negative and gram-positive microbiota in non-tumor and tumor tissue samples. Values in the venn
diagram represent the genera shared by and exclusive to non-tumor and tumor tissue libraries.
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found to be higher in one group were either less abundant
or even absent in other group. This indicates close interac-
tions within the microbial communities’ along with relative
microbial shift at two target sites. Our earlier study on
DGGE fingerprints of saliva samples from OSCC and
healthy subjects have shown significant group-specific
clusters despite inter- subject variability that may enable
to differentiate OSCC from healthy subjects [40].
This was further substantiated by the results of 16S
clonal analysis showing relatively distinct bacterial affilia-
tions at non-tumor and tumor sites of OSCC subjects.
Firmicutes were highly prevalent at tumor site as
observed earlier [37,38,40]. About 25 genera were com-
mon to both sites. There were differences in the relative
abundance of bacteria, however, no statistically signifi-
cant differences in phylogenies were detected at tumor
and non-tumor sites of the OSCC patients except for
genus Johnsonella (p< 0.1). The bacterial species asso-
ciated with tumor tissues were far more diverse than that
previously shown by culture-dependent [10,33-36] and
culture-independent studies [38]. The predominance of
gram-positive bacteria relative to gram-negative bacteria
suggests differences in the bacterial communities at two
clinically distinctive sites. These oral bacteria may act as
a primary trigger or precursor of mucosal lesions or sec-
ondary invaders in non-infectious mucosal lesions [33].
An interesting observation related to clonal analysis
was that the sequences when matched with the two
known databases, RDP and HOMD for highest similarity
showed similar results up to genus level. But at species
level, the uncultivable phylotypes detected were 3.83%
and ~60% by HOMD and RDP respectively. This may be
due to differences in basic structure of two databases.
Unlike RDP, HOMD is a curated database with 626 spe-
cies and phylotypes based on 98.5% similarity cutoffs of
full 1540-base 16S rRNA sequences and each oral taxon
assigned a specific number.
Most of the cultivable bacteria, Actinomyces sp. oral
taxon 181, Streptococcus sp. oral taxon 071, P. histicola, P.
pallens, Selenomonas sputigena, V. dispar and phylotype,
Leptotrichia sp. oral taxon 215 present in non-tumor
tissues are known putative representatives of predomin-
ant genera in healthy oral microbiome [69]. Prevotella has
earlier been associated with different types of endodontic
infections [70] and Leptotrichia an opportunistic patho-
gen with bacteremia or sepsis producing lactic acid as a
major metabolic end product [71]. Granulicatella
adiacens which was highly prevalent in non-tumor group
is also a known agent of endocarditis [72]. S. intermedius
was predominant in 70% of OSCC subjects at both non-
tumor and tumor sites. S. parasangunis II and O. sinus
were also present at both sites. Oribacterium species are
weakly fermentative forming metabolic end products,
acetic and lactic acid [73]. S. anginosus detected at 4 non-
tumor and 2 tumor sites has been reported earlier in
OSCC specimens [36,38] and saliva of alcoholics [74].
The Streptococcus anginosus group comprised of three
species, S. anginosus, S. constellatus and S. intermedius
Figure 5 Relative distribution of total bacteria (cultivable species and uncultured phylotypes) in tissues from non-tumor and tumor
sites of OSCC subjects characterized by HOMD. Core of pie chart shows percentage distribution of total 914 filtered sequences in terms of
their % homology to curated 16S rRNA sequences in HOMD. Outer concentric of pie chart depicts the oral bacterial taxa in combined library;
sequences with >98% identity: named cultured species (78.6%), unnamed cultured species (5.9%) and yet-uncultured phylotypes (3.8%); and
sequences with <98% identity (11.7%) were considered as unclassified sequences characterized only to genus level. Venn diagrams correlates
with the corresponding section of pie chart as indicated by line except for the unclassified sequences. Inset values in two subsets (non-tumor
and tumor) represents observed bacterial species unique to that particular library. Values in overlapping section of subsets reflect oral taxa
common to both sites.
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and are normal flora in humans, these bacteria are
pathogens associated strongly with abscess formation
and with infection in multiple body sites [75]. Assachar-
olytic Eubacterium and closely related strains found in
our study at tumor sites are major bacterial groups in
oral lesions and play important role in infections of root
canal and periodontal pockets and use proteins and
peptides derived from tissues and blood as energy
source [76]. Also, Atopobium, F. nucleatum ss. vincentii
and Parvimonas have been associated with endodontic
infections or periodontitis [40,77,78]. Together, these
observed species at tumor sites substantiates its associ-
ation with some early primary infection of lesion that
may act as a trigger for tumor initiation and progres-
sion [79].
Streptococci were more prevalent at tumor sites as also
reported earlier [10,34,35,80]. We observed Streptococcus
sp. oral taxon 058, Peptosteptococcus stomatis, S. salivarius,
S. gordonii, G. haemolysans, G. morbillorum, J. ignava and
S. parasanguinis I, to be associated with tumor site. Van
a.
b.
Figure 6 Prevalence of bacterial species/phylotypes associated with non-tumor and tumor sites of OSCC subjects corresponding to
phyla: (a) Bacteroidetes, Proteobacteria, Fusobacteria, Actinobacteria, uncultured TM7; and (b) Firmicutes, as detected by HOMD.
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Houte et al. [81,82] identified significant populations
of Streptococci which produced large amounts of acid
(pH< 4.2 in broth) in both coronal caries and root-
surface caries. Streptococci are saccharolytic producing
short chain organic acid from carbohydrates, thus
lowering the pH of their local environment [83] and
also aciduric P. stomatis found in oral cavity is weakly
saccharolytic and produces fermented products, acetic,
butyric, isobutyric, isovaleric and isocaproic acids [84].
These microbiota may contribute to the acidic and
hypoxic microenvironment of tumors [85,86] and
promote bacterial colonization. Anaerobes, Gemella
species like any other commensal are opportunistic
pathogens known to cause serious local and systemic
infections mainly in immune-suppressed patients
[40,87] were detected at tumor sites [35,40]. J. ignava
can be a predicted new pathogen not detected in earlier
studies and known to be associated with gingivitis and
periodontitis [88].
Studies have shown association of tooth loss or peri-
odontal diseases and oral cancer [89-91]. Periodontal
disease is often linked to cardiovascular disease, low-
birth weight complications in pregnancy, diabetes and
pulmonary disease and certain cancers including oral
cancer [79]. The common factor between periodontal
disease and cancer is inflammation driven by bacteria.
At this point of time, it is not clear whether changes in
bacterial colonization act as a trigger to lesion forma-
tion. However, once the lesion is formed which may be
spontaneous or due to underlying changes in the host
tissues as a result of external factors such as smoking,
drinking or oral health, specific oral bacteria can
colonize and induce inflammation. Oral bacteria have
shown ability to adhere, co-aggregate or colonize on
specific surfaces in oral cavity representing tissue trop-
ism as reported in several studies [92,93].
The involvement of infection-triggered inflammations
has been estimated in the pathogenesis of approximately
15–20% of human tumors [17,94]. Recently, it has
been shown that two specific bacterial subpopulations,
Enterobacteriaceae and Tenericutes lead to increase in
methylation of multidrug resistance gene1 (MDR1 gene)
and bacterial-triggered inflammation that correlates
with regional nodal metastases over adjacent normal
mucosa [63].
Mager et al. [93] demonstrated significant differences
in the bacterial profiles of 40 oral cultivable species on
soft and hard tissues in healthy subjects and found dis-
tinct profiles of the soft tissues than those of supragingi-
val and subgingival plaques. Using culture-independent
molecular technique, Aas et al. [92] analyzed samples
of nine sites from five healthy subjects and showed
the site and subject specificity of bacterial colonization
in the healthy human oral cavity. In our study too,
despite the homogenous population, several species were
site-specific, while others were subject-specific and
undergo succession from health to disease. Hence, even
a slight distinction in bacterial community at non-tumor
and tumor sites has significance as the samples were
from two adjoining sites of same OSCC subject.
The underlying species-specific shift implicates altera-
tions in bacterial colonization at tumor sites. The trans-
location of bacteria from oral cavity to cervical lymph
nodes and more in metastatic than in uninvolved nodes
in oral cancer patients has been reported by Sakamoto
et al. [35].
Conclusions
Together, the results indicate that certain bacterial spe-
cies/phylotypes detected in this study may play a role in
triggering chronic inflammation in oral cavity and pos-
sibly be associated at different stages of cancer [95]. This
may be due to disrupted oral mucosal surface allowing
bacterial invasion and perhaps serve as point of entry to
the regional lymph nodes [33,35]. This indicates that
though the bacterial biota were commensals of oral cav-
ity and may become pathogenic when their balance is
disturbed. Microbial shift or dysbiosis has been impli-
cated in some diseases due to unequal ratio of beneficial
symbionts to pathogens [96]. This study recognized
association of some new bacterial species, like J. ignava
not detected earlier in tumor samples by culture-
dependent or independent methods. However, these
studies were performed with limited sample size. There-
fore, further investigation with larger sample size using
high throughput sequencing would validate these find-
ings and broaden our perspective on bacterial associ-
ation and oral cancer.
Table 2 Richness, diversity indices and coverage
estimation in individual and combined libraries
N T Combined
(n= 10) (n= 10) (n= 20)
No. of clones 414 500 914
Species/phylotypes (S) 57 59 80
Singletons 16 22 21
Doubletons 9 7 13
Chao1 estimator of species richness 71.22 93.57 96.96
Chao1 standard deviation 9.34 20.56 9.69
ACE estimator of species richness 68.59 83.76 97.78
Shannon’s index for diversity (H) 3.37 3.20 3.47
Simpson’s index for diversity (1-D) 0.94 0.92 0.94
Evenness (e^H/S) 0.51 0.42 0.40
Good’s estimator of coverage (%) 96.14 95.6 97.7
N–non-tumor; T–tumor; Combined–non-tumor and tumor; n–number
of samples.
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